KHC Sales Tick Up as Turnaround Invests Heavily, But Volume Proof Still Elusive

What happened

Kraft Heinz reported a slight uptick in first-quarter sales, following a $600M reinvestment plan launched in early 2026 to reverse volume-led declines and regain market share. The improvement, while modest, aligns with management's goal of achieving share momentum in the second half of the year, as marketing spend rose toward 5.5% of sales and R&D increased 20%. However, the DeepValue report highlights that FY2025 volume/mix sank 4.1pp and the company still faces a daunting -3.5% to -1.5% organic sales guidance for FY2026. The Berkshire Hathaway resale overhang (up to 325M shares) and paused separation plan add further uncertainty, keeping sentiment fragile. Until consolidated volume/mix turns positive by Q3 2026, the reinvestment risk remains that higher spending becomes margin dilution rather than growth.

Implication

KHC’s modest sales improvement is a data point that the reinvestment plan may be gaining traction, but the thesis remains unproven. The stock's ~$23 price reflects pessimistic expectations; if volume/mix inflects positively by H2 2026, the stock could rererate toward $26 base case. However, without proof, the risk of margin dilution and Berkshire overhang caps upside. Hold for evidence, or trim if volume fails to improve by Q3 2026.

Thesis delta

The slight sales uptick provides a glimmer of hope that the reinvestment plan is not failing outright, but the core volume-led decline has not yet reversed. The thesis shifts from pure skepticism to a more balanced 'wait for proof' stance: the reinvestment inputs are visible, but the output (volume stabilization) is still missing. The confidence in a turnaround edges up marginally but remains low until Q3 2026 data confirms broader share gains.